Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 May 31;9(6):1650. doi: 10.3390/jcm9061650

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

(a) Change in microbiota composition of a patient before and after A-FMT with respect to Bacteroidetes species as compared to the donor. In the A-FMT (fresh fecal microbiota transplantation (FMT) following triple antibiotic therapy (amoxicillin, fosfomycin, and metronidazole)) group, the change in the composition of Bacteroidetes species in 10 samples (donor, patient before FMT, at 2 weeks, 1, 2, 3, 5, 6, 12, and 24 months after FMT) in case #11. (b) Example of long-term endoscopic outcome after A-FMT. Case #11: A 30-year-old man with a history of extensive ulcerative colitis for three years. He did not take any medication, such as 5-aminosalicylate treatment, PSL or anti-TNFα. He received A-FMT (fresh fecal microbiota transplantation (FMT) following triple antibiotic therapy (amoxicillin, fosfomycin, and metronidazole)) from his younger brother.